Article Listing - South Korean pharmaceuticals market set to expand at 7.1% CAGR
PROCTER & GAMBLE PHARMACEUTICALS
27 April 1992
Norwich Eaton has now taken the name Procter and Gamble Pharmaceuticals. The change, according to company, is a sign of...
CANADA APPROVES INTERFERON ALFA
27 April 1992
The sale of two new products to treat patients infected with the hepatitis B virus has been approved in Canada....
ISRAELI INDUSTRY FACES PRICE PRESSURE
27 April 1992
In Israel, there have been demands that Hevrat Haovdim and the General Sick Fund, both...
CPMP MEETING DECISIONS
27 April 1992
At a recent meeting of the European Community's Committee for Pro-prietary Medicinal Products, four multi-state and nine concertation (eight variations)...
POST-ELECTION OUTLOOK FOR UK HEALTH SECTOR
20 April 1992
The UK Health and Household sector looks set to continue its period of consolidation and to underperform the stock market...
GEHE SALES AND PROFITS grow IN 1991
20 April 1992
German Drug manufacturer Gehe made group sales in 1991 of just over 5 billion Deutschemarks ($3 billion), an increase of...
US Rx DRUG PRICES UP 4.1% IN 1ST QUARTER
20 April 1992
The US Bureau of Labor Statistics reports that prices of prescription drug products increased by an average of 4.1% in...
STOCK MARKET COMMENTARY: TOKYO
20 April 1992
TOKYO: finished the week with a 6.5% loss at 17,236 yen on Monday April 13, despite a sharp 1,252 point...
APPOINTMENTS AT MARION MERRELL DOW
20 April 1992
Appointments at Marion Merrell Dow: Allan Mills is named as product director for cardiovascular products; Norman Craig is appointed as...
EFAs COULD REFORM ANTIVIRAL THERAPY
20 April 1992
A new approach to treating viral infections, and one which could be synergistic with other antiviral strategies, was described in...
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- CIS countries prepare for the introduction of drug reimbursement schemes
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
